Emerging trends in pharmaceutical design and drug manufacturing are shifting toward presenting the market with new ways to develop medications. Specialty medications continue to be a major area of pharmaceutical development and have become widely discussed in workers’ comp due to their significant costs. Although they represent approximately 1% of drug utilization, they account for nearly 7% of prescription drug costs and represent the fastest-growing segment of the U.S. pharmaceutical market. While specialty drug products are often associated with a hefty price tag, some can offer clinical advantages when deployed for the right patient at the right time, making careful oversight and patient selection imperative to achieving desired outcomes in this space. Watch the video blog to learn more.
More stories
WorkCompWire
Article
Drug Dispensing Channels Bring Unique Challenges
Mitchell
News Release
Latest Mitchell Report Details Collision Claim and Repair Differences Between Electric and Internal Combustion Engine Vehicles
Higher average severity for electric automobiles is offset by lower non-drivable frequency post-accident SAN DIEGO, Calif.—
Mitchell
Conference
CIECA Connex Conference 2023
CIECA Connex 2023 is an engaging, two-day conference on the theme “Connected Car | Connected Industry”.
Workers' Comp
Article
Mindfulness: What Is It?
What is mindfulness? Mindfulness can help you quiet your mind, relax your body, and reduce stress.
Workers' Comp
Podcast
Why Opioid Trends Are Changing in Workers’ Comp
Workers' Comp
Article
Ask The Pharmacist: Biologics and Approved Biosimilar Drugs in Workers’ Compensation
What are biological and biosimilar drugs? It is likely you have heard the terms biological o